期刊
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
卷 19, 期 1, 页码 2-7出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/13651501.2014.961931
关键词
Dementia; guidelines; Alzheimer's disease; Lewy body disease; anti-dementia drugs; neuropsychiatric symptoms
类别
资金
- Lundbeck
- AstraZeneca
- Teva
- GlaxoSmithKline
- Eli Lilly
- Pfizer
- Roche
- Bristol-Myers Squibb
- CSC
- Janssen Pharmaceutica
- MSD
- Novartis
- Organon
- Pierre Fabre
- Schwabe
- Sepracor
- Servier
- Wyeth
- Janssen Cilag
- Otsuka
- NIH [P50 AG05142, R01 AG033288, R01 AG037561]
- State of California
- Alzheimer's Association
- Baxter
- Genentech
- Johnson Johnson
- Abbvie Laboratories
- AC Immune
- Allon
- Biogen Idec
- Biotie
- Ela
- EnVivo
- Merck
- Piramal
- Sanofi
- Takeda
- Tau Rx
- Toyama
- Zinfandel
- Dainippon Sumitomo Pharma Co Ltd
- National Institute for Health Research [NF-SI-0512-10033] Funding Source: researchfish
Objective. To define a practice guideline for biological treatment of dementias for general practitioners in primary care. Methods. TThis paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Biological treatment of Alzheimer's disease and other dementias for treatment in primary care (Ihl et al. 2011). The recommendations were developed by a task force of international experts in the field and are based on randomized controlled studies. Results. Anti-dementia medications neither cure, nor arrest, or alter the course of the disease. The type of dementia, the individual symptom constellation and the tolerability and evidence for efficacy should determine what medications should be used. In treating neuropsychiatric symptoms, psychosocial intervention should be the treatment of first choice. For neuropsychiatric symptoms, medications should only be considered when psychosocial interventions are not adequate and aft er cautious risk-benefit analysis. Conclusions. Depending on the diagnostic entity and clinical presentation different anti-dementia drugs can be recommended. These guidelines provide a practical approach for general practitioners managing dementias.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据